BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7502329)

  • 1. Dapsone syndrome.
    Dhamija R; Kumar D; Khurana G
    Trop Doct; 1995 Oct; 25(4):176-7. PubMed ID: 7502329
    [No Abstract]   [Full Text] [Related]  

  • 2. Dapsone hypersensitivity or viral exanthem?
    Ramam M; Srivastava P
    Acta Derm Venereol; 2004; 84(4):334-5; author reply 335-6. PubMed ID: 15339092
    [No Abstract]   [Full Text] [Related]  

  • 3. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone syndrome with acute renal failure during leprosy treatment: case report.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Fontes CJ
    Braz J Infect Dis; 2005 Feb; 9(1):84-6. PubMed ID: 15947852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between HLA-B*1301 and dapsone-induced hypersensitivity reactions among leprosy patients in China.
    Wang H; Yan L; Zhang G; Chen X; Yang J; Li M; Shen J; Yu M; Huo R; Wang B
    J Invest Dermatol; 2013 Nov; 133(11):2642-2644. PubMed ID: 23604100
    [No Abstract]   [Full Text] [Related]  

  • 6. A lethal case of the dapsone hypersensitivity syndrome involving the myocardium.
    Hoogeveen RM; van der Bom T; de Boer HH; Thurlings RM; Wind BS; de Vries HJ; van Lent AU; Beuers U; van der Wal AC; Nellen FJ
    Neth J Med; 2016 Feb; 74(2):89-92. PubMed ID: 26951355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
    Ranawaka RR; Mendis S; Weerakoon HS
    Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B*13:01 and the dapsone hypersensitivity syndrome.
    Zhang FR; Liu H; Irwanto A; Fu XA; Li Y; Yu GQ; Yu YX; Chen MF; Low HQ; Li JH; Bao FF; Foo JN; Bei JX; Jia XM; Liu J; Liany H; Wang N; Niu GY; Wang ZZ; Shi BQ; Tian HQ; Liu HX; Ma SS; Zhou Y; You JB; Yang Q; Wang C; Chu TS; Liu DC; Yu XL; Sun YH; Ning Y; Wei ZH; Chen SL; Chen XC; Zhang ZX; Liu YX; Pulit SL; Wu WB; Zheng ZY; Yang RD; Long H; Liu ZS; Wang JQ; Li M; Zhang LH; Wang H; Wang LM; Xiao P; Li JL; Huang ZM; Huang JX; Li Z; Liu J; Xiong L; Yang J; Wang XD; Yu DB; Lu XM; Zhou GZ; Yan LB; Shen JP; Zhang GC; Zeng YX; de Bakker PI; Chen SM; Liu JJ
    N Engl J Med; 2013 Oct; 369(17):1620-8. PubMed ID: 24152261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone hypersensitivity syndrome in an adolescent during treatment during of leprosy.
    Bucaretchi F; Vicente DC; Pereira RM; Tresoldi AT
    Rev Inst Med Trop Sao Paulo; 2004; 46(6):331-4. PubMed ID: 15654479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal.
    Rao PN; Lakshmi TS
    Lepr Rev; 2001 Mar; 72(1):57-62. PubMed ID: 11355519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone hypersensitivity syndrome among leprosy patients in China.
    Tian W; Shen J; Zhou M; Yan L; Zhang G
    Lepr Rev; 2012 Dec; 83(4):370-7. PubMed ID: 23614255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side-effects of antileprosy drugs in common use.
    Jopling WH
    Lepr Rev; 1983 Dec; 54(4):261-70. PubMed ID: 6199637
    [No Abstract]   [Full Text] [Related]  

  • 13. Dapsone hypersensitivity syndrome with coexisting acute hepatitis E.
    Chogle A; Nagral A; Soni A; Agale S; Jamadar Z
    Indian J Gastroenterol; 2000; 19(2):85-6. PubMed ID: 10812824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sparing of tuberculoid leprosy patch in a patient with dapsone hypersensitivity syndrome.
    Ng PP; Goh CL
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):646-8. PubMed ID: 9777777
    [No Abstract]   [Full Text] [Related]  

  • 15. Different roads, same destination.
    Wang B
    J Invest Dermatol; 2014 Apr; 134(4):1154-1155. PubMed ID: 24390133
    [No Abstract]   [Full Text] [Related]  

  • 16. Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
    Sheen YS; Chu CY; Wang SH; Tsai TF
    J Dermatolog Treat; 2009; 20(6):340-3. PubMed ID: 19954390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of linear immunoglobulin A disease with dapsone hypersensitivity and its management strategies.
    Verma R; Vasudevan B; Sagar A; Pragasam V; Deb P; Choden G
    Indian J Dermatol Venereol Leprol; 2013; 79(6):833-5. PubMed ID: 24177627
    [No Abstract]   [Full Text] [Related]  

  • 18. Dapsone syndrome: an incomplete form.
    Jaswal R; Thami GP; Kanwar AJ
    Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
    Narasimharao P; Pratap DV; Suneetha S
    Lepr Rev; 2009 Mar; 80(1):81-4. PubMed ID: 19472855
    [No Abstract]   [Full Text] [Related]  

  • 20. Dapsone agranulocytosis in a leprosy patient.
    Hiran S; Pande TK; Pani S; Vishwanathan KA
    Lepr Rev; 1994 Sep; 65(3):279-81. PubMed ID: 8942159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.